Beta Drugs Limited (NSE:BETA)
2,231.90
+28.50 (1.29%)
At close: Jul 31, 2026
31.40% (1Y)
| Market Cap | 22.53B +31.4% |
| Revenue (ttm) | 4.10B +10.1% |
| Net Income | 455.86M +8.8% |
| EPS | 44.31 +6.8% |
| Shares Out | 10.09M |
| PE Ratio | 50.37 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,918 |
| Open | 2,192.20 |
| Previous Close | 2,203.40 |
| Day's Range | 2,184.00 - 2,341.90 |
| 52-Week Range | 990.10 - 2,674.00 |
| Beta | -0.45 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 20, 2026 |